Canada Hormone Replacement Therapy Market Size & Outlook
Related Markets
Canada hormone replacement therapy market highlights
- The Canada hormone replacement therapy market generated a revenue of USD 541.8 million in 2024 and is expected to reach USD 1,053.4 million by 2033.
- The Canada market is expected to grow at a CAGR of 7.8% from 2025 to 2033.
- In terms of segment, parathyroid hormone replacement was the largest revenue generating product in 2024.
- Testosterone Replacement Therapy is the most lucrative product segment registering the fastest growth during the forecast period.
Hormone replacement therapy market data book summary
| Market revenue in 2024 | USD 541.8 million |
| Market revenue in 2033 | USD 1,053.4 million |
| Growth rate | 7.8% (CAGR from 2025 to 2033) |
| Largest segment | Parathyroid hormone replacement |
| Fastest growing segment | Testosterone Replacement Therapy |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Estrogen and Progesterone Replacement Therapy, HGH replacement therapy, Thryoid hormone replacement therapy, Testosterone Replacement Therapy, Parathyroid Hormone replacement |
| Key market players worldwide | Eli Lilly and Co, Bayer AG, Hisamitsu Pharmaceutical Co Inc, Pfizer Inc, Merck & Co Inc, Viatris Inc, Novo Nordisk A/S ADR, AbbVie Inc, Roche Holding AG ADR, Ascend Wellness Holdings Inc |
Other key industry trends
- In terms of revenue, Canada accounted for 2.3% of the global hormone replacement therapy market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. hormone replacement therapy market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,053.4 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hormone Replacement Therapy Market Scope
Hormone Replacement Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Ascend Wellness Holdings Inc | View profile | 1500 | 1411 Broadway, 16th Floor, New York, NY, United States, 10018 | https://www.awholdings.com |
| Hisamitsu Pharmaceutical Co Inc | View profile | 3682 | 408 Tashiro Daikan-machi, Tosu, Saga, Japan, 841-0017 | http://www.hisamitsu.co.jp |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Canada hormone replacement therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hormone replacement therapy market will help companies and investors design strategic landscapes.
Parathyroid hormone replacement was the largest segment with a revenue share of 51.11% in 2024. Horizon Databook has segmented the Canada hormone replacement therapy market based on estrogen and progesterone replacement therapy, hgh replacement therapy, thryoid hormone replacement therapy, testosterone replacement therapy, parathyroid hormone replacement covering the revenue growth of each sub-segment from 2021 to 2033.
Canada is anticipated to witness lucrative growth in the coming years. Increasing disease awareness, improved screening, developments in its healthcare infrastructure, and growing healthcare expenditure per capita are among factors supporting market growth. According to an NCBI article, one in 10 people in Canada is affected with thyroid disease.
However, the diagnosis rate for thyroid is lower than expected in the country. According to Thyroid Foundation of Canada, the reason for low diagnosis rate is that people have accepted it as a common hereditary disorder, and the disease gets attention mostly when the gland gets awry. Such factors raise the demand for thyroid hormone replacement therapy. Increase in the prevalence of GHD is another factor expected to drive market growth.
In Canada, Turner syndrome is diagnosed in one out of every 2,500 live female births. According to Turner Syndrome Society of Canada, over 6,000 women are suffering from the disease in the country. Prader-Willi syndrome affects men and women equally; it occurs in one out of 15,000 births.
Reasons to subscribe to Canada hormone replacement therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada hormone replacement therapy market databook
-
Our clientele includes a mix of hormone replacement therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada hormone replacement therapy market , including forecasts for subscribers. This country databook contains high-level insights into Canada hormone replacement therapy market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Canada hormone replacement therapy market size, by product, 2021-2033 (US$M)
Canada Hormone Replacement Therapy Market Outlook Share, 2024 & 2033 (US$M)
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
